Home > > > > Report Detail

China Flu Vaccine Market Report & Forecast 2021-2027

Publisher Name :
Date: 23-Aug-2021
No. of pages: 92
Inquire Before Buying

This report contains market size and forecasts of Flu Vaccine in China, including the following market information:

China Flu Vaccine Market Revenue, 2016-2021, 2022-2027, ($ millions)

China Flu Vaccine Market Sales, 2016-2021, 2022-2027, (M Doses)

China top five Flu Vaccine companies in 2020 (%)

The global Flu Vaccine market size is expected to growth from US$ 5154 million in 2020 to US$ 7293.3 million by 2027; it is expected to grow at a CAGR of 4.8% during 2021-2027.

The China Flu Vaccine market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.

QYResearch has surveyed the Flu Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

China Flu Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

China Flu Vaccine Market Segment Percentages, By Type, 2020 (%)

- Trivalent Influenza Vaccine

- Quadrivalent Influenza Vaccine

China Flu Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

China Flu Vaccine Market Segment Percentages, By Application, 2020 (%)

- For Children (6 months to 3 years)

- For Adults and Children over 3 years

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Flu Vaccine revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Flu Vaccine revenues share in China market, 2020 (%)

Key companies Flu Vaccine sales in China market, 2016-2021 (Estimated), (M Doses)

Key companies Flu Vaccine sales share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Sanofi Pasteur

- CSL

- GSK

- Mylan

- Hulan Bio

- AstraZeneca

- CCBIO

China Flu Vaccine Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Flu Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Flu Vaccine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Flu Vaccine Overall Market Size
2.1 China Flu Vaccine Market Size: 2021 VS 2027
2.2 China Flu Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 China Flu Vaccine Sales: 2016-2027
3 Company Landscape
3.1 Top Flu Vaccine Players in China Market
3.2 Top China Flu Vaccine Companies Ranked by Revenue
3.3 China Flu Vaccine Revenue by Companies
3.4 China Flu Vaccine Sales by Companies
3.5 China Flu Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Flu Vaccine Companies in China Market, by Revenue in 2020
3.7 Manufacturers Flu Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Flu Vaccine Players in China Market
3.8.1 List of Tier 1 Flu Vaccine Companies in China
3.8.2 List of Tier 2 and Tier 3 Flu Vaccine Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Flu Vaccine Market Size Markets, 2021 & 2027
4.1.2 Trivalent Influenza Vaccine
4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type - China Flu Vaccine Revenue & Forecasts
4.2.1 By Type - China Flu Vaccine Revenue, 2016-2021
4.2.2 By Type - China Flu Vaccine Revenue, 2022-2027
4.2.3 By Type - China Flu Vaccine Revenue Market Share, 2016-2027
4.3 By Type - China Flu Vaccine Sales & Forecasts
4.3.1 By Type - China Flu Vaccine Sales, 2016-2021
4.3.2 By Type - China Flu Vaccine Sales, 2022-2027
4.3.3 By Type - China Flu Vaccine Sales Market Share, 2016-2027
4.4 By Type - China Flu Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Flu Vaccine Market Size, 2021 & 2027
5.1.2 For Children (6 months to 3 years)
5.1.3 For Adults and Children over 3 years
5.2 By Application - China Flu Vaccine Revenue & Forecasts
5.2.1 By Application - China Flu Vaccine Revenue, 2016-2021
5.2.2 By Application - China Flu Vaccine Revenue, 2022-2027
5.2.3 By Application - China Flu Vaccine Revenue Market Share, 2016-2027
5.3 By Application - China Flu Vaccine Sales & Forecasts
5.3.1 By Application - China Flu Vaccine Sales, 2016-2021
5.3.2 By Application - China Flu Vaccine Sales, 2022-2027
5.3.3 By Application - China Flu Vaccine Sales Market Share, 2016-2027
5.4 By Application - China Flu Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Corporation Information
6.1.2 Sanofi Pasteur Overview
6.1.3 Sanofi Pasteur Flu Vaccine Sales and Revenue in China Market (2016-2021)
6.1.4 Sanofi Pasteur Flu Vaccine Product Description
6.1.5 Sanofi Pasteur Recent Developments
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Overview
6.2.3 CSL Flu Vaccine Sales and Revenue in China Market (2016-2021)
6.2.4 CSL Flu Vaccine Product Description
6.2.5 CSL Recent Developments
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Overview
6.3.3 GSK Flu Vaccine Sales and Revenue in China Market (2016-2021)
6.3.4 GSK Flu Vaccine Product Description
6.3.5 GSK Recent Developments
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Overview
6.4.3 Mylan Flu Vaccine Sales and Revenue in China Market (2016-2021)
6.4.4 Mylan Flu Vaccine Product Description
6.4.5 Mylan Recent Developments
6.5 Hulan Bio
6.5.1 Hulan Bio Corporation Information
6.5.2 Hulan Bio Overview
6.5.3 Hulan Bio Flu Vaccine Sales and Revenue in China Market (2016-2021)
6.5.4 Hulan Bio Flu Vaccine Product Description
6.5.5 Hulan Bio Recent Developments
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Overview
6.6.3 AstraZeneca Flu Vaccine Sales and Revenue in China Market (2016-2021)
6.6.4 AstraZeneca Flu Vaccine Product Description
6.6.5 AstraZeneca Recent Developments
6.7 CCBIO
6.7.1 CCBIO Corporation Information
6.7.2 CCBIO Overview
6.7.3 CCBIO Flu Vaccine Sales and Revenue in China Market (2016-2021)
6.7.4 CCBIO Flu Vaccine Product Description
6.7.5 CCBIO Recent Developments
7 China Flu Vaccine Production Capacity, Analysis
7.1 China Flu Vaccine Production Capacity, 2016-2027
7.2 Flu Vaccine Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Flu Vaccine Supply Chain Analysis
9.1 Flu Vaccine Industry Value Chain
9.2 Flu Vaccine Upstream Market
9.3 Flu Vaccine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Flu Vaccine Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Flu Vaccine in China Market
Table 2. Top Flu Vaccine Players in China Market, Ranking by Revenue (2019)
Table 3. China Flu Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Flu Vaccine Revenue Share by Companies, 2016-2021
Table 5. China Flu Vaccine Sales by Companies, (M Doses), 2016-2021
Table 6. China Flu Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Flu Vaccine Price (2016-2021) & (US$/Dose)
Table 8. Manufacturers Flu Vaccine Product Type
Table 9. List of Tier 1 Flu Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Flu Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Trivalent Influenza Vaccine
Table 12. Major Manufacturers of Quadrivalent Influenza Vaccine
Table 13. By Type - China Flu Vaccine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Flu Vaccine Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Flu Vaccine Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Flu Vaccine Sales (M Doses), 2016-2021
Table 17. By Type - China Flu Vaccine Sales (M Doses), 2022-2027
Table 18. By Application - China Flu Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Flu Vaccine Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Flu Vaccine Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Flu Vaccine Sales (M Doses), 2016-2021
Table 22. By Application - China Flu Vaccine Sales (M Doses), 2022-2027
Table 23. Sanofi Pasteur Corporation Information
Table 24. Sanofi Pasteur Description and Major Businesses
Table 25. Sanofi Pasteur Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 26. Sanofi Pasteur Flu Vaccine Product
Table 27. Sanofi Pasteur Recent Developments
Table 28. CSL Corporation Information
Table 29. CSL Description and Major Businesses
Table 30. CSL Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 31. CSL Flu Vaccine Product
Table 32. CSL Recent Developments
Table 33. GSK Corporation Information
Table 34. GSK Description and Major Businesses
Table 35. GSK Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 36. GSK Flu Vaccine Product
Table 37. GSK Recent Developments
Table 38. Mylan Corporation Information
Table 39. Mylan Description and Major Businesses
Table 40. Mylan Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 41. Mylan Flu Vaccine Product
Table 42. Mylan Recent Developments
Table 43. Hulan Bio Corporation Information
Table 44. Hulan Bio Description and Major Businesses
Table 45. Hulan Bio Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 46. Hulan Bio Flu Vaccine Product
Table 47. Hulan Bio Recent Developments
Table 48. AstraZeneca Corporation Information
Table 49. AstraZeneca Description and Major Businesses
Table 50. AstraZeneca Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 51. AstraZeneca Flu Vaccine Product
Table 52. AstraZeneca Recent Developments
Table 53. CCBIO Corporation Information
Table 54. CCBIO Description and Major Businesses
Table 55. CCBIO Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 56. CCBIO Flu Vaccine Product
Table 57. CCBIO Recent Developments
Table 58. Flu Vaccine Production Capacity (M Doses) of Key Manufacturers in China Market, 2019-2021 (M Doses)
Table 59. China Flu Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 60. Flu Vaccine Market Opportunities & Trends in China Market
Table 61. Flu Vaccine Market Drivers in China Market
Table 62. Flu Vaccine Market Restraints in China Market
Table 63. Flu Vaccine Raw Materials
Table 64. Flu Vaccine Raw Materials Suppliers in China Market
Table 65. Typical Flu Vaccine Downstream
Table 66. Flu Vaccine Downstream Clients in China Market
Table 67. Flu Vaccine Distributors and Sales Agents in China Market
List of Figures
Figure 1. Flu Vaccine Product Picture
Figure 2. Flu Vaccine Segment by Type
Figure 3. Flu Vaccine Segment by Application
Figure 4. China Flu Vaccine Market Overview: 2020
Figure 5. China Flu Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Flu Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. Flu Vaccine Sales in China Market: 2016-2027 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Flu Vaccine Revenue in 2020
Figure 9. Trivalent Influenza Vaccine Product Picture
Figure 10. Quadrivalent Influenza Vaccine Product Picture
Figure 11. By Type - China Flu Vaccine Sales Market Share, 2016-2027
Figure 12. By Type - China Flu Vaccine Revenue Market Share, 2016-2027
Figure 13. By Type - China Flu Vaccine Price (US$/Dose), 2016-2027
Figure 14. For Children (6 months to 3 years)
Figure 15. For Adults and Children over 3 years
Figure 16. By Application - China Flu Vaccine Sales Market Share, 2016-2027
Figure 17. By Application - China Flu Vaccine Revenue Market Share, 2016-2027
Figure 18. By Application - China Flu Vaccine Price (US$/Dose), 2016-2027
Figure 19. Sanofi Pasteur Flu Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. CSL Flu Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. GSK Flu Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Mylan Flu Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Hulan Bio Flu Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. AstraZeneca Flu Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. CCBIO Flu Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. China Flu Vaccine Production Capacity (M Doses), 2016-2027
Figure 27. Flu Vaccine Industry Value Chain
Figure 28. Marketing Channels
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs